Quick Answer
Lunai Bioworks Inc. reported Diluted EPS of $1.08 per share (loss) for fiscal year 2025.
Lunai Bioworks Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$1.08 | -18.7% |
| 2024 | -$0.91 | -28.2% |
| 2023 | -$0.71 | +67.1% |
| 2022 | -$2.16 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | -$0.08 | +82.2% | -161.5% |
| September 30, 2025 | $0.13 | +104.7% | — |
| March 31, 2025 | $0.00 | +100.0% | +100.0% |
| December 31, 2024 | -$0.45 | -542.9% | +83.7% |
| September 30, 2024 | -$2.76 | -1871.4% | -411.1% |
| March 31, 2024 | -$0.54 | -575.0% | -671.4% |
| December 31, 2023 | -$0.07 | +12.5% | +50.0% |
| September 30, 2023 | -$0.14 | +0.0% | -75.0% |
- Lunai Bioworks Inc. showed a decrease of -18.7% in Diluted EPS compared to the prior fiscal year.
- Over the 2022–2025 period, Lunai Bioworks Inc.’s diluted eps has grown by 50.0% (from $2.16 per share (loss) to $1.08 per share (loss)).
- The most recent figure is from Lunai Bioworks Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on September 29, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: